2018
Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs
MEADER, Ellie, Tomáš BÁRTA, Dario MELGUIZO-SANCHIS, Katarzyna TILGNER, David MONTANER et. al.Základní údaje
Originální název
Pluripotent Stem Cell-Derived Hematopoietic Progenitors Are Unable to Downregulate Key Epithelial-Mesenchymal Transition-Associated miRNAs
Autoři
MEADER, Ellie (826 Velká Británie a Severní Irsko), Tomáš BÁRTA (203 Česká republika, domácí), Dario MELGUIZO-SANCHIS (826 Velká Británie a Severní Irsko), Katarzyna TILGNER (826 Velká Británie a Severní Irsko), David MONTANER (724 Španělsko), Ashraf A. EL-HAROUNI (682 Saúdská Arábie), Lyle ARMSTRONG (826 Velká Británie a Severní Irsko) a Majlinda LAKO (826 Velká Británie a Severní Irsko, garant)
Vydání
Stem Cells, Hoboken, Wiley-Blackwell, 2018, 1066-5099
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10601 Cell biology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.614
Kód RIV
RIV/00216224:14110/18:00102112
Organizační jednotka
Lékařská fakulta
UT WoS
000418942500007
Klíčová slova anglicky
Human embryonic stem cells; miRNAs; Epithelial-mesenchymal transition; Hematopoietic differentiation
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 10. 2. 2019 17:25, Soňa Böhmová
Anotace
V originále
Hematopoietic stem cells derived from pluripotent stem cells could be used as an alternative to bone marrow transplants. Deriving these has been a long-term goal for researchers. However, the success of these efforts has been limited with the cells produced able to engraft in the bone marrow of recipient animals only in very low numbers. There is evidence that defects in the migratory and homing capacity of the cells are due to mis-regulation of miRNA expression and are responsible for their failure to engraft. We compared the miRNA expression profile of hematopoietic progenitors derived from pluripotent stem cells to those derived from bone marrow and found that numerous miRNAs are too highly expressed in hematopoietic progenitors derived from pluripotent stem cells, and that most of these are inhibitors of epithelial-mesenchymal transition or metastasis (including miR-200b, miR-200c, miR-205, miR-148a, and miR-424). We hypothesize that the high expression of these factors, which promote an adherent phenotype, may be causing the defect in hematopoietic differentiation. However, inhibiting these miRNAs, individually or in multiplex, was insufficient to improve hematopoietic differentiation in vitro, suggesting that other miRNAs and/or genes may be involved in this process.